Author

Antony J

Associate Professor, Department of Pharmacology, JSS College of Pharmacy, Ooty, Tamilnadu, India - Cited by 376 - Neuropharmacology - Cerebral Ischemia - Alzheimer's

Biography

Dr. Antony J is working as a Department of Pharmacology, JSS College of Pharmacy, JSS University, Ootacamund, Mysuru, India.His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.    
Title
Cited by
Year
Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles.
JA Natarajan J, Baskaran M, Humtsoe LC, Vadivelan RArtificial Cells, Nanomedicine, and Biotechnology: An International Journal, 1-8, 201656201
56
2016
40
2012
Minutes of PPAR-γ agonism and neuroprotection
BRP Kumar, AP Kumar, JA Jose, P Prabitha, S Yuvaraj, S Chipurupalli, ...Neurochemistry International 140, 104814, 2020202
34
2020
Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels.
RM Justin A, Sathishkumar M, Sudheer A, Shanthakumari SPharmacology Biochemistry Behavaviour 122, 61-73, 201431201
31
2014
Telmisartan mediates anti-inflammatory and not cognitive function through PPAR-γ agonism via SARM and MyD88 signaling
SP Balaji, CV Chand, A Justin, M RamanathanPharmacology Biochemistry and Behavior 137, 60-68, 2015201
28
2015
Rational design, synthesis, and in vitro neuroprotective evaluation of novel glitazones for PGC-1α activation via PPAR-γ: a new therapeutic strategy for neurodegenerative disorders
A Justin, S Mandal, P Prabitha, S Dhivya, S Yuvaraj, P Kabadi, SJ Sekhar, ...Neurotoxicity research 37, 508-524, 2020202
19
2020
Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT1 and not AT2 receptor
A Justin, S Divakar, M RamanathanBiomedicine & Pharmacotherapy 102, 947-958, 2018201
16
2018
Glitazones, PPAR-γ and neuroprotection
AP Kumar, BR Kumar, V Jeyarani, SP Dhanabal, A JustinMini Reviews in Medicinal Chemistry 21 (12), 1457-1464, 2021202
11
2021
Coumarin-Fatty acid conjugates as potential ERα/AKT-1 Antagonists for ER positive breast cancer
J Selvaraj, J John, NM Joghee, J Antony, A Wadhwani, J NatarajanAnti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020202
8
2020
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics.
A Justin, AK TD, M Chinaswamy, BRP KumarACS Chemical Neuroscience 12 (13), 221-2272, 2021202
6
2021
6
2020
Positive allosteric activation of glial EAAT-2 transporter protein: a novel strategy for Alzheimer’s disease
C Manisha, A Selvaraj, S Jubie, CMJ Nanjan, NM Joghee, JP Clement, ...Medical Hypotheses 142, 109794, 2020202
5
2020
In-vitro cell line Models and Assay methods to study the Anti-diabetic Activity
J Antony, S Debroy, C Manisha, P Thomas, V Jeyarani, T ChoephelResearch Journal of Pharmacy and Technology 12 (), 2200-2206, 2019201
5
2019
Comparative study on the beneficial effects of telmisartan and other antihypertensive agents in stroke patients
A Jose, D Wilson, M George, RK Thomas, A JustinInt J Pharm Pharm Sci 9 (2), 99-102, 2017201
3
2017
Targeting efficacy of simvastatin for hormone-dependent carcinomas through solid lipid nanoparticles
JM Dasam, J Natarajan, V Karri, AD Wadhwani, J AntonyJournal of Nanomedicine and Nanotechnology 7 (6), 1-7, 2016201
3
2016
Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER-positive Breast Cancer Therapy
Dual Modulators of p5 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER-positive Breast Cancer TherapyP Naresh, A Wadhwani, S JubieMini Reviews in Medicinal Chemistry 21 (7), 792-802, 2021202
3
2021